William T. Budd, Ph.D.
Affiliations: | 2012 | Integrative Life Sciences | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Cell Biology, Bioinformatics Biology, System Science Engineering, OncologyGoogle:
"William Budd"Mean distance: (not calculated yet)
Parents
Sign in to add mentorZendra Elizabeth Zehner | grad student | 2012 | VCU | |
(Combinatorial analysis of tumorigenic microRNAs driving prostate cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Seashols-Williams SJ, Budd W, Clark GC, et al. (2016) miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis. Plos One. 11: e0159601 |
Budd WT, Seashols-Williams SJ, Clark GC, et al. (2015) Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis. Plos One. 10: e0142373 |
Budd WT, Seashols S, Weaver D, et al. (2013) A networks method for ranking microRNA dysregulation in cancer. Bmc Systems Biology. 7: S3 |
Budd WT, Weaver DE, Anderson J, et al. (2012) microRNA dysregulation in prostate cancer: network analysis reveals preferential regulation of highly connected nodes. Chemistry & Biodiversity. 9: 857-67 |
Budd WT, Weaver DE, Calvert V, et al. (2012) Abstract B54: miR-125b and miR-17-3p: Newly identified tumor suppressors for prostate cancer Cancer Research. 72: B54-B54 |
Zhang X, Ladd A, Dragoescu E, et al. (2009) MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clinical & Experimental Metastasis. 26: 965-79 |